Eliza PS Tsou, PhD
Frederick G L Huetwell Research Professor of Rheumatology II
Assistant Professor in Internal Medicine
Internal Medicine/Rheumatology
2800 Plymouth Road, Building 20, Room 1822
Ann Arbor, Michigan 48109
[email protected]

Available to mentor

Eliza PS Tsou, PhD
Assistant Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
  • Qualifications
    • PhD
      University at Buffalo/ State University of New York, Buffalo, 2008
    • BSc
      National Taiwan University, Taipei City, 2001
    Center Memberships
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    Recent Publications See All Publications
    • Journal Article
      Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.
      Ma F, Tsou P-S, Gharaee-Kermani M, Plazyo O, Xing X, Kirma J, Wasikowski R, Hile GA, Harms PW, Jiang Y, Xing E, Nakamura M, Ochocki D, Brodie WD, Pillai S, Maverakis E, Pellegrini M, Modlin RL, Varga J, Tsoi LC, Lafyatis R, Kahlenberg JM, Billi AC, Khanna D, Gudjonsson JE. Nat Commun, 2024 Jan 3; 15 (1): 210 DOI:10.1038/s41467-023-44645-6
      PMID: 38172207
    • Journal Article
      Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa.
      van Straalen KR, Ma F, Tsou P-S, Plazyo O, Gharaee-Kermani M, Calbet M, Xing X, Sarkar MK, Uppala R, Harms PW, Wasikowski R, Nahlawi L, Nakamura M, Eshaq M, Wang C, Dobry C, Kozlow JH, Cherry-Bukowiec J, Brodie WD, Wolk K, Uluçkan Ö, Mattichak MN, Pellegrini M, Modlin RL, Maverakis E, Sabat R, Kahlenberg JM, Billi AC, Tsoi LC, Gudjonsson JE. J Clin Invest, 2024 Feb 1; 134 (3): DOI:10.1172/JCI169225
      PMID: 38051587
    • Journal Article
      Senescent Cells Accumulate in Systemic Sclerosis Skin.
      Shi B, Tsou P-S, Ma F, Mariani MP, Mattichak MN, LeBrasseur NK, Chini EN, Lafyatis R, Khanna D, Whitfield ML, Gudjonsson JE, Varga J. J Invest Dermatol, 2023 Apr; 143 (4): 661 - 664.e5. DOI:10.1016/j.jid.2022.09.652
      PMID: 36191640
    • Journal Article
      Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog.
      Kortam N, Liang W, Shiple C, Huang S, Gedert R, Clair JS, Sarosh C, Foster C, Tsou P-S, Varga J, Knight JS, Khanna D, Ali RA. Arthritis Res Ther, 2024 Jul 25; 26 (1): 139 DOI:10.1186/s13075-024-03379-6
      PMID: 39054558
    • Proceeding / Abstract / Poster
      LB860 Cross-disease comparison of dermatomyositis and SLE identifies non-classical monocytes and JAK-1 signaling as drivers of endothelial cell death in DM skin
      Hile G, Ma F, Tsou P, Gharaee-Kermani M, Zhang L, Victory A, Hurst A, Xu B, Pedersen E, Wasikowski R, Berthier C, Ognenovski V, Nakamura M, Billi A, Gudjonsson JE, Kahlenberg M. Journal of Investigative Dermatology, 2024 Aug; 144 (8): s150 DOI:10.1016/j.jid.2024.06.1240
    • Journal Article
      Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways.
      Gurrea-Rubio M, Wang Q, Mills EA, Wu Q, Pitt D, Tsou P-S, Fox DA, Mao-Draayer Y. Int J Mol Sci, 2024 Feb 20; 25 (5): DOI:10.3390/ijms25052454
      PMID: 38473703
    • Journal Article
      Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.
      Gurrea-Rubio M, Wu Q, Amin MA, Tsou P-S, Campbell PL, Amarista CI, Ikari Y, Brodie WD, Mattichak MN, Muraoka S, Randon PM, Lind ME, Ruth JH, Mao-Draayer Y, Ding S, Shen X, Cooney LA, Lin F, Fox DA. Cancer Immunol Immunother, 2024 Jan 27; 73 (2): 34 DOI:10.1007/s00262-023-03578-1
      PMID: 38280067
    • Journal Article
      Senescence and tissue fibrosis: opportunities for therapeutic targeting.
      O'Reilly S, Tsou P-S, Varga J. Trends Mol Med, 2024 Jun 17; DOI:10.1016/j.molmed.2024.05.012
      PMID: 38890028
    Featured News & Stories microscope
    Health Lab
    Targeting and blocking sCD13 protein could lead to systemic sclerosis treatment
    Targeting and blocking the sCD13 protein from interacting with the B1R protein can pave the way for new fibrosis and systemic sclerosis treatments.